Decoy Therapeutics Develops Scalable Peptide-Conjugate Manufacturing for Global Access Decoy Therapeutics has announced a collaboration with the Gates Foundation to create a scalable manufacturing platform for peptide-conjugate antivirals aimed at improving global access, especially in low-income countries.

Decoy Therapeutics Develops Scalable Peptide-Conjugate Manufacturing for Global Access #USA #Gates_Foundation #Cambridge #Decoy_Therapeutics #IMP3ACT_platform